JOHN WAY Insider Trading $PRLB Proto Labs Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN WAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN WAY. JOHN WAY is Chief Financial Officer in Proto Labs Inc ($PRLB).
JOHN WAY in Proto Labs Inc
Trading Symbol: PRLBIndustry: FABRICATED STRUCTURAL METAL PRODUCTS [3440]
Position of JOHN WAY: Chief Financial Officer
Holdings: 29,224 shares
Current Value: $1,496,269
Latest Transaction: Feb 18 2021
$PRLB Market Capitalization: $1.36B
$PRLB Previous Close: $51.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN WAY in Proto Labs Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 180.46 | 3,128 | 564,479 | 3,128 | |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 4,433 | 0 | 33,657 | 29.2 K to 33.7 K (+15.17 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 197.05 | 2,171 | 427,796 | 29,224 | 31.4 K to 29.2 K (-6.92 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 180.46 | 3,128 | 564,479 | 3,128 | |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 4,433 | 0 | 33,657 | 29.2 K to 33.7 K (+15.17 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 197.05 | 2,171 | 427,796 | 29,224 | 31.4 K to 29.2 K (-6.92 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 62.90 | 2,608 | 164,043 | 0 | |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 57.88 | 8,348 | 483,182 | 2,837 | |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 67.15 | 4,995 | 335,414 | 0 | |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 133.66 | 200 | 26,731 | 31,150 | 31.4 K to 31.2 K (-0.64 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 132.53 | 2,050 | 271,683 | 31,350 | 33.4 K to 31.4 K (-6.14 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 131.44 | 13,701 | 1,800,831 | 33,400 | 47.1 K to 33.4 K (-29.09 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 62.90 | 2,608 | 164,043 | 47,101 | 44.5 K to 47.1 K (+5.86 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 57.88 | 8,348 | 483,182 | 44,493 | 36.1 K to 44.5 K (+23.10 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 67.15 | 4,995 | 335,414 | 36,145 | 31.2 K to 36.1 K (+16.04 %) |
Feb 12 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 96.72 | 5,501 | 532,057 | 5,501 | |
Feb 12 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 4,607 | 0 | 32,906 | 28.3 K to 32.9 K (+16.28 %) |
Dec 03 2019 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 95.83 | 195 | 18,687 | 28,299 | 28.5 K to 28.3 K (-0.68 %) |
Feb 15 2019 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 108.47 | 1,435 | 155,654 | 28,021 | 29.5 K to 28 K (-4.87 %) |
Dec 19 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 126.93 | 291 | 36,937 | 25,212 | 25.5 K to 25.2 K (-1.14 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 57.88 | 3,000 | 173,640 | 11,185 | |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 67.15 | 5,000 | 335,750 | 4,995 | |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 160.14 | 4,644 | 743,692 | 25,503 | 30.1 K to 25.5 K (-15.40 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 157.66 | 3,356 | 529,105 | 30,147 | 33.5 K to 30.1 K (-10.02 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 57.88 | 3,000 | 173,640 | 33,503 | 30.5 K to 33.5 K (+9.84 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 67.15 | 5,000 | 335,750 | 30,503 | 25.5 K to 30.5 K (+19.61 %) |
Aug 28 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 62.90 | 3,912 | 246,065 | 2,608 | |
Aug 28 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 146.25 | 1,486 | 217,332 | 25,503 | 27 K to 25.5 K (-5.51 %) |
Aug 28 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 145.51 | 2,426 | 353,005 | 26,989 | 29.4 K to 27 K (-8.25 %) |
Aug 28 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 62.90 | 3,912 | 246,065 | 29,415 | 25.5 K to 29.4 K (+15.34 %) |
Feb 16 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 106.45 | 1,148 | 122,205 | 25,717 | 26.9 K to 25.7 K (-4.27 %) |
Feb 14 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 105.75 | 4,291 | 453,773 | 4,291 | |
Feb 14 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 105.75 | 3,745 | 396,034 | 26,865 | 23.1 K to 26.9 K (+16.20 %) |
Feb 15 2017 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 58.35 | 6,805 | 397,072 | 6,805 | |
Feb 15 2017 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 58.35 | 9,645 | 562,786 | 22,675 | 13 K to 22.7 K (+74.02 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 26.45 | 14,185 | 375,193 | 14,185 | |
Feb 10 2016 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 57.88 | 6,480 | 375,062 | 12,626 | 6.1 K to 12.6 K (+105.43 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 67.15 | 9,995 | 671,164 | 9,995 | |
Feb 11 2015 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 2,610 | 0 | 5,790 | 3.2 K to 5.8 K (+82.08 %) |
Page: 1